UNSPSC 51192003: Probenecid

This classification denotes a uricosuric agent with the molecular formula C13H19NO4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PO572Z7917, chemically known as 4-(n,n-dipropylsulfamoyl)benzoesaeure but generally known as probenecid, which bears US NIH Compound Identifier 4911. European Medicines Agency schedules Probenecid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10053MIG.

UNSPSC 51192003 Probenecid is a Commodity code that nominally covers a specific uricosuric medication used to treat gout and hyperuricemia. However, the recent state and local opportunities tagged under this code show little alignment with pharmaceutical procurement — the three most recent postings involve a District Attorney's Office dog, athletic training services for fire and police departments, and medical aid supplies (bandages, antiseptic sprays, first aid kits, and aspiration). The code appears to carry minimal relevance to actual state and local pharmaceutical buying or to the specific drug named in the taxonomy.

The geographic spread of recent activity is limited to Oregon, Arizona, and Florida, with no clear pattern of repeat buyers or concentrated demand. Washington County, Oregon posted an RFP for a District Attorney's Office Dog (due August 14, 2026); the City of Tucson posted an RFP for athletic training services for its Fire and Police Departments (due June 9, 2026, with a non-mandatory pre-submittal meeting on May 19, 2026); and the City of Tampa's Fire Rescue Department posted an ITB for medical aid supplies including first aid kits and emergency blankets (due April 9, 2025, with a $100,000 total department budget and 5% bid discounts available to City-certified Small Local Business Enterprises and Underutilized Woman and Minority Owned Business Enterprises). The mismatch between the code's pharmaceutical scope and the opportunities posted suggests either a classification error in the state and local database or that probenecid procurement does not drive measurable activity at the state and local level.